Elicio Therapeutics (ELTX) vs Nasus Pharma (NSRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nasus Pharma (NSRX) has outperformed Elicio Therapeutics (ELTX) over the past year, losing 50.1% versus a loss of 82.9%. Elicio Therapeutics is the larger company by market cap ($47.6 million vs $42.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELTX | NSRX |
|---|---|---|
| Share price | $1.81 | $3.63 |
| Market cap | $47.57M | $42.52M |
| 1-day change | -2.16% | -3.84% |
| YTD return | -76.76% | -60.33% |
| 1-year return | -82.85% | -50.07% |
| 5-year return | -97.87% | — |
| EPS (TTM) | $-2.16 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.00 | $9.50 |
| 52-week low | $1.71 | $1.98 |
| Distance from 52-week high | -88.69% | -61.79% |
| Average volume | 352.93K | 16.09K |
| Shares outstanding | 26.28M | 11.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NSRX has outperformed ELTX by 32.8 percentage points over the past year.
ELTX vs NSRX FAQ
Which is bigger, Elicio Therapeutics or Nasus Pharma?
Elicio Therapeutics (ELTX) is larger, with a market capitalization of $47.57M compared with $42.52M for Nasus Pharma (NSRX).
Which stock has performed better over the past year, ELTX or NSRX?
NSRX returned -50.07% over the past 12 months, compared with -82.85% for ELTX (price return, excluding dividends). Past performance does not predict future results.
Are Elicio Therapeutics and Nasus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.